Welcome to the world's most comprehensive range of mitochondrial antibodies, mitochondrial assays, and mitochondrial toxicity screening products.   We manufacture all of our monoclonal antibodies and research kits, we use them in our own research, and all of our products are 100% guaranteed.

New Products
Assays for Mitochondrial Biogenesis
Understanding the up- and down-regulation of mitochondrial biogenesis has become increasingly important in a variety of research areas, and it is also of crucial importance to developers of antibiotic and antiviral drugs. Two new kits are now available for both clinical and high-throughput analysis of mitochondrial biogenesis.

MSA42 Microplate Assay Kit for Apoptosis-Inducing Factor (AIF)
AIF is a multi-functional protein with a vital oxidoreductase function, an anti-oxidant activity, an assembly function in Complex I formation, and an apoptogenic function. MSA42 is complementary to the MSA31 Dipstick Assay for AIF.

MSF41 Microplate Assay Kit for Frataxin
A 96-well assay suitable for frataxin researchers and drug developers working on therapies for Friedreich's Ataxia. MSF41 is complementary to the MSF31 Dipstick Assay for Frataxin.

MSF42 Recombinant Human Frataxin
For use in generating reference standard curves with MSF31 and MSF41 frataxin assay kits.

Featured Resource
The Complex IV Playbook
Download our free guide to conducting research into cytochrome c oxidase using tools from MitoSciences. Complex IV deficiency has been implicated in diseases such as Alzheimer's Disease and cancer.

Complex IV (cytochrome c oxidase) Playbook The Complex IV Playbook

Featured Products
Assay Kits for Mitochondrial Trifunctional Protein (MTP)
Inherited deficiency of MTP is a genetic disease which occurs in approximately 1:38,000 newborns in the US. Deficiency of LCHAD (the dehydrogenase part of MTP) has also been found in children of women who develop HELLP syndrome and AFLP syndrome, both of which are life-threatening obstetric conditions. Furthermore, heterozygous individuals for MTP defects are more susceptible to nonalcoholic hepatic steatosis, or nonalcoholic fatty liver disease (NAFLD), the most common form of liver disease in the US.

News
April 15 - MitoSciences and the University of Oregon announce exclusive biotechnology transfer agreement. Click here for the complete press release.

April 9 - MitoSciences and Invitrogen announce distribution and co-development agreement. Click here for the complete press release.

March 16 - MitoSciences has launched the MitoTox™ line of products and services for mitochondrial toxicity screening. MitoTox™ offers the most complete set of solutions for understanding drug-induced mechanisms of mitochondrial inhibition.

Company news archive
PRODUCTS FOR LIFE SCIENCES RESEARCH
SERVICES FOR DRUG DISCOVERY AND TOXICOLOGY
MITOPROFILE MULTIPLEXING PRODUCTS
OXPHOS EVALUATION KITS
DIAGNOSTIC PRODUCTS


"The activity dipsticks you sell have surpassed my expectations...they have proven to be extremely reliable and sensitive. I will certainly be purchasing these and similar items from you in the future...your tech support is also extremely helpful."

- Dr. Luke H. Stockwin
- National Cancer Institute


Contract Research
Volume Discounts
Downloadable Protocols
MitoNews Email Bulletin
MitoPoints Rewards Program
International Distributors
Home - About Us - Products - Support - Resources - Careers - Contact Us - Shopping Cart

Sales & Customer Support:
1-800-910-6486
sales@mitosciences.com

Copyright © 2004-2008 MitoSciences Inc. All rights reserved.